QSA's Week in Healthcare (#3, 2025)
Bilateral agreement on rare disease drugs; workplace mental health toolkit; Saint John community health funding; national non-smoking week statement.
Start Date: 2025-01-18
End Date: 2025-01-24
Top Headlines
Main Stories
Bilateral Agreement for Rare Disease Drug Access
The Government of Canada, alongside Ontario, announced a bilateral agreement worth over $535 million to improve access to drugs for rare diseases. The agreement aims to make five specific drugs available, including Poteligeo and Yescarta, targeting rare conditions like mycosis fungoides and large B-cell lymphoma. This collaboration is part of the National Strategy for Rare Diseases, focusing on affordability and early diagnosis across provinces. The initiative aligns with broader efforts to enhance drug coverage and health outcomes for Canadians living with rare diseases.
Sources: ['Announcements: www.canada.ca']
Toolkit Launch for Workplace Mental Health
The Canadian Centre for Occupational Health and Safety has released a free Workplace Mental Health Toolkit. This resource aims to equip Canadian businesses with tools to foster a supportive mental health environment. It includes checklists, videos, and infographics designed to aid in developing comprehensive mental health programs. This initiative links mental health to broader human rights, promoting psychologically safe workplaces and potentially impacting organizational culture positively.
Sources: ['Announcements: www.canada.ca']
